Cardiovascular Medicine Department, Assiut University Heart Hospital, Assiut University, Assiut, Egypt.
Radiodiagnosis Department, Assiut University Hospital, Assiut University, Assiut, Egypt.
BMC Cardiovasc Disord. 2023 May 17;23(1):255. doi: 10.1186/s12872-023-03292-x.
There is a close relationship between blood pressure levels and the risk of cardiovascular events, strokes, and kidney disease. For many years, the gold standard instrument for blood pressure measurement was a mercury sphygmomanometer and a stethoscope, but this century-old technique of Riva-Rocci/Korotkov is being progressively removed from clinical practice. Central blood pressure is considered better than peripheral blood pressure in predicting cardiovascular events, as it assesses wave reflections and viscoelastic properties of the arterial wall which make systolic and pulse pressures vary from central to peripheral arteries, but mean blood pressure is constant in the conduit arteries.
The study included 201 patients with primary hypertension (108 patients with chronic kidney disease and 93 patients without kidney disease). All patients underwent blood pressure measurement by OMRON M2 and Mobil-O-Graph devices, kidney function assessment and abdominal ultrasonography.
Patients with chronic kidney disease were significantly older (60.02 ± 9.1 vs. 55.33 ± 8.5; P < 0.001), with longer duration of hypertension (7.56 ± 5.9 vs. 6.05 ± 5.8; P = 0.020) in comparison to those without chronic kidney disease. Automated peripheral measurement of systolic blood pressure, diastolic blood pressure and pulse pressure were significantly higher in comparison to central blood pressure. Patients with chronic kidney disease had significantly higher augmentation index (24.06 ± 12.6 vs. 19.02 ± 10.8; P < 0.001) and pulsed wave velocity (8.66 ± 1.5 vs. 8.69 ± 6.8; P = 0.004) in comparison to those without chronic kidney disease. Augmentation index had positive correlation with pulse wave velocity (r = 0.183, P = 0.005). There was negative correlation between both pulse wave velocity and augmentation index and estimated glomerular filtration rate (r = -0.318, P < 0.001), and (r = -0.236, P < 0.001), respectively. Hence, arterial stiffness parameters are good positive test for prediction of chronic kidney disease.
There is a strong agreement between non-invasive centrally and automated peripherally measured blood pressure in diagnosis of hypertension. But non-invasive central measurements are preferred over automated measurements for early prediction and detection of renal impairment.
血压水平与心血管事件、中风和肾脏疾病的风险密切相关。多年来,血压测量的金标准仪器是汞柱血压计和听诊器,但这种已有百年历史的里瓦-罗奇/科罗托科夫技术正逐渐从临床实践中消失。中心血压比外周血压更能预测心血管事件,因为它评估了动脉壁的反射波和粘弹性特性,使收缩压和脉压从中心动脉到外周动脉发生变化,但在导管动脉中平均血压是恒定的。
该研究纳入了 201 例原发性高血压患者(慢性肾脏病患者 108 例,无肾脏病患者 93 例)。所有患者均接受欧姆龙 M2 和 Mobil-O-Graph 设备的血压测量、肾功能评估和腹部超声检查。
与无慢性肾脏病的患者相比,慢性肾脏病患者明显更年长(60.02±9.1 岁 vs. 55.33±8.5 岁;P<0.001),高血压病程更长(7.56±5.9 岁 vs. 6.05±5.8 岁;P=0.020)。与中心血压相比,自动外周测量的收缩压、舒张压和脉压明显较高。慢性肾脏病患者的增强指数(24.06±12.6 比 19.02±10.8;P<0.001)和脉搏波速度(8.66±1.5 比 8.69±6.8;P=0.004)明显更高。增强指数与脉搏波速度呈正相关(r=0.183,P=0.005)。脉搏波速度和增强指数与估算肾小球滤过率呈负相关(r=-0.318,P<0.001)和(r=-0.236,P<0.001)。因此,动脉僵硬度参数是预测慢性肾脏病的良好阳性试验。
在诊断高血压方面,无创中心血压和自动外周血压测量具有很强的一致性。但是,对于早期预测和检测肾脏损害,无创中心测量优于自动测量。